Xanthine oxidase inhibitor and therapeutic treatment using same
AssigneeSiegfried Aktiengesellschaft
InventorsKurt Thiele, James S. G. Cox, Johanna Fischer, Ulrich Jahn
Life of this patent
Estimating the term…
Abstract
Therapeutic xanthine oxidase inhibitor composition containing as an active ingredient 3-dimethylamino-7-methyl-1,2-(n-propylmalonyl)-1,2-dihydro-1,2,4-benzotria zine dihydrate of the formula ##STR1## Uratic diathesis in warm-blooded animals is therapeutically treated by administering the aforementioned xanthine oxidase inhibitor to such animals, e.g., human, either orally or by means of an injection, thereby inhibiting their xanthine oxidase activity.
Claims9
A process for the therapeutic treatment of a warm blooded animal suffering from uratic diathesis which process comprises administering to said animal, in an amount effective to inhibit xanthine oxidase therein, a composition comprising as a principal active ingredient a compound of the formula ##STR4##
Dependencies are inferred from the claim text.